06/24/2025

Sarapeta released a safety update on HCPCS Code J1413 – ELEVIDYS, announcing that it has suspended shipments of the infusion used for non-ambulatory patients with Duchenne muscular dystrophy. The company’s update is based on recent adverse events.  

Blue Cross and Blue Shield of Texas will work with providers to halt the administration of the drug. The Texas Health and Human Services Commission will provide us guidance on pending prior authorization criteria.

If you have questions or require assistance, please reach out to our Medicaid Provider Network Team at 855-212-1615 or by email.